Clinical Trial 46755

Tucson, AZ 85704


Summary:

A phase 1/2/3 Randomized Study to evaluate the safety tolerability and immunogenicity of a modified RNV vaccine against influenza in healthy individuals.


Qualified Participants May Receive:

Qualified participants will receive $400.00 for every completed study visit. 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.